ATPC Stock Chart & Stats
$2.49
-$0.03(-2.50%)
At close: 4:00 PM EST
$2.49
-$0.03(-2.50%)
Day’s Range― - ―
52-Week Range$1.72 - $75.25
Previous Close$1.16
Volume35.37K
Average Volume (3M)43.34K
Market Cap
$2.96M
Enterprise Value$2.69M
Total Cash (Recent Filing)$24.34M
Total Debt (Recent Filing)$180.40K
Price to Earnings (P/E)―
Beta0.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.92
Shares Outstanding1,000,626
10 Day Avg. Volume33,490
30 Day Avg. Volume43,335
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.19
Price to Sales (P/S)2.80
P/FCF Ratio-1.77
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue1.78
Enterprise Value/Gross Profit3.29
Enterprise Value/Ebitda-1.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Agape ATP News
ATPC FAQ
What was Agape ATP’s price range in the past 12 months?
Agape ATP lowest stock price was $1.72 and its highest was $75.25 in the past 12 months.
What is Agape ATP’s market cap?
Agape ATP’s market cap is $2.96M.
When is Agape ATP’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Agape ATP’s earnings last quarter?
Currently, no data Available
Is Agape ATP overvalued?
According to Wall Street analysts Agape ATP’s price is currently Overvalued.
Does Agape ATP pay dividends?
Agape ATP does not currently pay dividends.
What is Agape ATP’s EPS estimate?
Agape ATP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Agape ATP have?
Agape ATP has 1,000,626 shares outstanding.
What happened to Agape ATP’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Agape ATP?
Currently, no hedge funds are holding shares in ATPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Agape ATP
Agape ATP Corporation, an investment holding enterprise, operates out of Malaysia, providing a variety of health and wellness products in addition to health solution advisory services. The company structures its extensive offerings into four main program categories: ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S., each encompassing a unique selection of goods and services. Its product range includes the ATP series, featuring ATP1s Survivor Select for essential bodily nutrients, ATP3 Ionized Cal-Mag as a vital calcium and magnesium supplement, ATP4 Omega Blend supplying crucial omega 3 and 6 fatty acids, and ATP5 BetaMaxx for immune system enhancement. Other products in this line address specific needs, such as AGN-Vege Fruit Fiber for digestive tract health, AGP1-Iron to combat iron deficiency, and YFA-Young Formula for anti-aging and youthful appearance maintenance. Under the BEAUNIQUE brand, consumers can find Mito+, an antioxidant beverage formulated for cellular, immune, metabolic, brain, and skin health, alongside Trim+, which works to inhibit carbohydrate digestion and reduce sugar absorption. The ÉNERGÉTIQUE brand specializes in skincare, offering various energy masks (Med-Hydration, Med-Whitening, Med-Firming), a hyaluronic acid serum, and a mousse facial cleanser. Additionally, the company markets soy protein isolate powder and an antioxidant under the Livo5 label. Beyond its product sales, Agape ATP Corporation actively advocates for a healthy lifestyle through online articles, structured programs, events, and public campaigns, while also delivering therapeutic health services. The company was founded in 2016 and maintains its corporate headquarters in Kuala Lumpur, Malaysia.
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---









